PortalPublikationenEjaculatory disorders may affect screening for prostate canc...

Ejaculatory disorders may affect screening for prostate cancer.

Standard

Ejaculatory disorders may affect screening for prostate cancer. / Walz, Jochen; Perrotte, Paul; Gallina, Andrea; Bénard, Francois; Valiquette, Luc; McCormack, Michael; Montorsi, Francesco; Karakiewicz, Pierre I.

in: J UROLOGY, Jahrgang 178, Nr. 1, 1, 2007, S. 232-238.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Walz, J, Perrotte, P, Gallina, A, Bénard, F, Valiquette, L, McCormack, M, Montorsi, F & Karakiewicz, PI 2007, 'Ejaculatory disorders may affect screening for prostate cancer.', J UROLOGY, Jg. 178, Nr. 1, 1, S. 232-238. <http://www.ncbi.nlm.nih.gov/pubmed/17499807?dopt=Citation>

APA

Walz, J., Perrotte, P., Gallina, A., Bénard, F., Valiquette, L., McCormack, M., Montorsi, F., & Karakiewicz, P. I. (2007). Ejaculatory disorders may affect screening for prostate cancer. J UROLOGY, 178(1), 232-238. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17499807?dopt=Citation

Vancouver

Walz J, Perrotte P, Gallina A, Bénard F, Valiquette L, McCormack M et al. Ejaculatory disorders may affect screening for prostate cancer. J UROLOGY. 2007;178(1):232-238. 1.

Bibtex

@article{fe3a10d02d504d8e88ef02b33b2fbca1,
title = "Ejaculatory disorders may affect screening for prostate cancer.",
abstract = "PURPOSE: Ejaculatory disorders will be experienced in most men who are treated for localized prostate cancer. Baseline rates of ejaculatory disorders are unknown in men at risk for prostate cancer. Therefore, we explored the prevalence of those disorders and associated bother in men without evidence of prostate cancer who participated in an annual prostate cancer screening event. MATERIALS AND METHODS: A cohort of 1,273 men without clinical evidence of prostate cancer completed the self-administered Danish Prostate Symptom Score for sexual dysfunction. This questionnaire quantifies the rate of reduced ejaculatory volume, ejaculatory pain and the rate of coexistent erectile dysfunction. RESULTS: Mean age was 57.6 years (range 40 to 89). Of all men 46% (563) had reduced ejaculatory volume and 66% (356) of affected men were bothered by this condition. Ejaculatory pain was reported in 11% (134) and 89% (118) of these men reported associated bother. Finally, 45% (554) reported erectile dysfunction and 73% (403) reported associated bother. Reduced ejaculatory volume was associated with erectile dysfunction (p",
author = "Jochen Walz and Paul Perrotte and Andrea Gallina and Francois B{\'e}nard and Luc Valiquette and Michael McCormack and Francesco Montorsi and Karakiewicz, {Pierre I}",
year = "2007",
language = "Deutsch",
volume = "178",
pages = "232--238",
journal = "J UROLOGY",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Ejaculatory disorders may affect screening for prostate cancer.

AU - Walz, Jochen

AU - Perrotte, Paul

AU - Gallina, Andrea

AU - Bénard, Francois

AU - Valiquette, Luc

AU - McCormack, Michael

AU - Montorsi, Francesco

AU - Karakiewicz, Pierre I

PY - 2007

Y1 - 2007

N2 - PURPOSE: Ejaculatory disorders will be experienced in most men who are treated for localized prostate cancer. Baseline rates of ejaculatory disorders are unknown in men at risk for prostate cancer. Therefore, we explored the prevalence of those disorders and associated bother in men without evidence of prostate cancer who participated in an annual prostate cancer screening event. MATERIALS AND METHODS: A cohort of 1,273 men without clinical evidence of prostate cancer completed the self-administered Danish Prostate Symptom Score for sexual dysfunction. This questionnaire quantifies the rate of reduced ejaculatory volume, ejaculatory pain and the rate of coexistent erectile dysfunction. RESULTS: Mean age was 57.6 years (range 40 to 89). Of all men 46% (563) had reduced ejaculatory volume and 66% (356) of affected men were bothered by this condition. Ejaculatory pain was reported in 11% (134) and 89% (118) of these men reported associated bother. Finally, 45% (554) reported erectile dysfunction and 73% (403) reported associated bother. Reduced ejaculatory volume was associated with erectile dysfunction (p

AB - PURPOSE: Ejaculatory disorders will be experienced in most men who are treated for localized prostate cancer. Baseline rates of ejaculatory disorders are unknown in men at risk for prostate cancer. Therefore, we explored the prevalence of those disorders and associated bother in men without evidence of prostate cancer who participated in an annual prostate cancer screening event. MATERIALS AND METHODS: A cohort of 1,273 men without clinical evidence of prostate cancer completed the self-administered Danish Prostate Symptom Score for sexual dysfunction. This questionnaire quantifies the rate of reduced ejaculatory volume, ejaculatory pain and the rate of coexistent erectile dysfunction. RESULTS: Mean age was 57.6 years (range 40 to 89). Of all men 46% (563) had reduced ejaculatory volume and 66% (356) of affected men were bothered by this condition. Ejaculatory pain was reported in 11% (134) and 89% (118) of these men reported associated bother. Finally, 45% (554) reported erectile dysfunction and 73% (403) reported associated bother. Reduced ejaculatory volume was associated with erectile dysfunction (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 178

SP - 232

EP - 238

JO - J UROLOGY

JF - J UROLOGY

SN - 0022-5347

IS - 1

M1 - 1

ER -